Mayne Pharma Group Ltd (MYX) — Cash Flow Quality Index
Mayne Pharma Group Ltd (MYX) has a Cash Flow Quality Index of -0.20x as of September 2022. Operating cash flow of AU$-28.40 Million is below net income of AU$145.01 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore MYX cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Mayne Pharma Group Ltd Cash Flow Quality Index (2010–2023)
Historical Cash Flow Quality Index for Mayne Pharma Group Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Mayne Pharma Group Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Mayne Pharma Group Ltd (2010–2023)
Year-by-year earnings quality comparison for Mayne Pharma Group Ltd. For live market cap and the full company financial profile, see Mayne Pharma Group Ltd market capitalisation.
| Year | Quality Index | Operating CF (AUD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -0.36x | AU$-42.71 Million | AU$117.25 Million | ▼ -111.7% |
| 2017 | -0.17x | AU$-15.24 Million | AU$88.57 Million | ▼ -112.0% |
| 2016 | 1.43x | AU$53.50 Million | AU$37.35 Million | ▼ -50.4% |
| 2015 | 2.89x | AU$22.42 Million | AU$7.76 Million | ▲ +135.4% |
| 2014 | 1.23x | AU$26.14 Million | AU$21.29 Million | ▼ -43.6% |
| 2012 | 2.18x | AU$13.39 Million | AU$6.15 Million | ▼ -10.6% |
| 2011 | 2.43x | AU$4.09 Million | AU$1.68 Million | ▼ -22.8% |
| 2010 | 3.15x | AU$10.26 Million | AU$3.25 Million | — |